Gainers
- Marinus Pharmaceuticals Inc MRNS shares rose 60% to $2.17 in pre-market trading after the company announced all patients in the Ganaxolone Phase 2 Refractory Status Epilepticus trial met the primary endpoint.
- Beyond Meat, Inc. BYND shares rose 11.3% to $154.00 in pre-market trading after McDonalds announced it will be testing Beyond Meat's plant-based burger in Southwestern Ontario.
- Rite Aid Corporation RAD rose 7.3% to $8.25 in pre-market trading after the company reported stronger-than-expected earnings for its second quarter.
- Frontline Ltd. FRO shares rose 7% to $9.54 in pre-market trading.
- DRDGOLD Limited DRD rose 7% to $5.17 in pre-market trading.
- PG&E Corporation PCG shares rose 5.6% to $11.37 in pre-market trading.
- DHT Holdings, Inc. DHT rose 5% to $ 6.31 in pre-market trading.
- Personalis, Inc. PSNL rose 4.5% to $17.15 in pre-market trading. Bank of America upgraded Personalis from Neutral to Buy.
- Ionis Pharmaceuticals, Inc. . IONS rose 4.4% to $64.00 in pre-market trading.
- Canopy Growth Corporation CGC rose 4.3% to $25.75 in pre-market trading after a report indicating the US House of Representatives passed the SAFE Banking Act.
- Cronos Group Inc. CRON rose 4.1% to $9.96 in pre-market trading after a report indicating the US House of Representatives passed the SAFE Banking Act. NOTE: The bill would allow financial institutions to bank state-legal cannabis companies.
- Aurora Cannabis Inc. ACB rose 4% to $4.95 in pre-market trading after a report indicating the US House of Representatives passed the SAFE Banking Act.
- Nabors Industries Ltd. NBR rose 3.8% to $2.17 in pre-market trading.
- Overstock.com, Inc. OSTK rose 3% to $12.60 in pre-market trading after gaining5.79% on Wednesday.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Check out these big penny stock gainers and losers
Losers
- Pearson plc PSO shares fell 16.7% to $8.83 in pre-market trading after the company announced it now expects adjusted operating profit in 2019 to be at the bottom of the guidance range of £590M - £640M and adjusted EPS at the bottom of the guidance range of 57.5P to 63.0P.
- Enanta Pharmaceuticals, Inc. ENTA shares fell 15.8% to $60.00 in pre-market trading. Enanta disclosed that ARGON-1 study of FXR Agonist, EDP-305, for the treatment of NASH met primary and key secondary endpoint. JP Morgan downgraded Enanta Pharmaceuticals from Neutral to Underweight and lowered the price target from $86 to $57.
- BioXcel Therapeutics, Inc. BTAI fell 10.8% to $8.75 in pre-market trading after the company reported the commencement of a $19 million common stock offering.
- SilverCrest Metals Inc. SILV fell 7.4% to $5.50 in the pre-market trading session.
- Plymouth Industrial REIT, Inc. PLYM fell 7.3% to $17.95 in the pre-market trading session after the company announced a 3 million common stock offering.
- HB Fuller Co FUL shares fell 5.8% to $44.75 in pre-market trading after the company reported worse-than-expected Q3 EPS and sales results. The company also issued FY19 EPS guidance below analyst estimates.
- Ctrip.com International, Ltd. CTRP fell 5.1% to $30.50 in pre-market trading after the company announces proposed 31.3 million share secondary offering of its American depositary shares.
- Crescent Point Energy Corp. CPG shares fell 3.8% to $4.27 in pre-market trading.
- Carnival Corporation & Plc CUK shares fell 3.1% to $45.00 in pre-market trading ahead of quarterly earnings.
- ArcelorMittal MT shares fell 2.5% to $14.11 in pre-market trading
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMoversTrading IdeasGeneralEnergyOil & Gas DrillingPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in